n-formylmethionine leucyl-phenylalanine and Tumor Lysis Syndrome

n-formylmethionine leucyl-phenylalanine has been researched along with Tumor Lysis Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chapman, PB; Houghton, AN; Minasian, LM; Morrison, ME; Nathan, CF; Rosenblum, M; Steffens, T; Szatrowski, TP; Williams, L1

Trials

1 trial(s) available for n-formylmethionine leucyl-phenylalanine and Tumor Lysis Syndrome

ArticleYear
Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-alpha and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma.
    Blood, 1994, Jan-01, Volume: 83, Issue:1

    Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; Gangliosides; Humans; Male; Melanoma; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Necrosis; Neutrophils; Recombinant Proteins; Tetradecanoylphorbol Acetate; Tumor Lysis Syndrome; Tumor Necrosis Factor-alpha

1994